Trials / Terminated
TerminatedNCT02378038
PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)
A Phase II Study of PNT2258 in Patients With Richter's Transformation (RT)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Sierra Oncology LLC - a GSK company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is sponsored by Sierra Oncology, Inc. formerly ProNAi Therapeutics, Inc. It is a multi-center, single-arm, 2-stage, open-label phase II investigation of PNT2258 to characterize anti-tumor activity and collect safety data on patients with Richter's Transformation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PNT2258 |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-03-04
- Last updated
- 2023-06-29
- Results posted
- 2020-03-10
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02378038. Inclusion in this directory is not an endorsement.